US Patent Issued to Eli Lilly and Co. on Sept. 1 for "GIPR-agonist compounds" (Indiana Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,063, issued on Sept. 1, was assigned to Eli Lilly and Co. (Indianapolis).

"GIPR-agonist compounds" was invented by Jorge Alsina-Fernandez (Indianapolis), Andrea Renee Geiser (Greenwood, Ind.), Lili Guo (Carmel, Ind.), Samantha Grace Lyons Keyser (Carmel, Ind.), John Lee (Carmel, Ind.), Hongchang Qu (Carmel, Ind.) and William Christopher Roell (Avon, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds having activity at the human glucose-dependent insulinotropic polypeptide (GIP) receptor. The present invention also relates to compounds having an extended duration of action at the GIP receptor. Such compound...